LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 59.85 | 27.76 | 83 | 6062 | 0.0137 | 0.1514 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 59.85 | 27.76 | 707 | 6062 | 0.1166 | 0.5168 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 59.85 | 27.76 | 1 | 6062 | 0.0002 | -0.3480 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 59.85 | 27.76 | 673 | 6062 | 0.1110 | 0.5072 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 61.56 | 27.76 | 93 | 6217 | 0.0150 | 0.1675 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 61.56 | 27.76 | 753 | 6217 | 0.1211 | 0.5262 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 61.56 | 27.76 | 1 | 6217 | 0.0002 | -0.3467 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 61.56 | 27.76 | 670 | 6217 | 0.1078 | 0.5035 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 63.26 | 27.76 | 73 | 6465 | 0.0113 | 0.1308 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 63.26 | 27.76 | 811 | 6465 | 0.1254 | 0.5360 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 63.26 | 27.76 | 1 | 6465 | 0.0002 | -0.3447 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 63.26 | 27.76 | 699 | 6465 | 0.1081 | 0.5072 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 64.97 | 27.76 | 90 | 6656 | 0.0135 | 0.1604 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 64.97 | 27.76 | 769 | 6656 | 0.1155 | 0.5222 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 64.97 | 27.76 | 1 | 6656 | 0.0002 | -0.3432 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 64.97 | 27.76 | 551 | 6656 | 0.0828 | 0.4593 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 66.67 | 27.76 | 98 | 6695 | 0.0146 | 0.1728 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 66.67 | 27.76 | 742 | 6695 | 0.1108 | 0.5146 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 66.67 | 27.76 | 1 | 6695 | 0.0001 | -0.3429 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 66.67 | 27.76 | 626 | 6695 | 0.0935 | 0.4825 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 68.37 | 27.76 | 108 | 6879 | 0.0157 | 0.1863 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 68.37 | 27.76 | 768 | 6879 | 0.1116 | 0.5181 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 68.37 | 27.76 | 1 | 6879 | 0.0001 | -0.3416 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 68.37 | 27.76 | 615 | 6879 | 0.0894 | 0.4763 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 70.08 | 27.76 | 114 | 6849 | 0.0166 | 0.1945 | MN20160318_Q01 | E14 |